Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

Bewaard in:

Bibliografische gegevens
Gepubliceerd in:	The New England Journal of Medicine vol. 384, no. 17 (Apr 29, 2021), p. 1589
Hoofdauteur:	Pergola, Pablo E
Andere auteurs:	Farag Youssef MK, Agarwal Rajiv, Arnold, Susan, Bako Gabriel, Block, Geoffrey A, Burke, Steven, Castillo, Fausto P, Jardine, Alan G, Khawaja Zeeshan, Koury, Mark J, Lewis, Eldrin F, Lin, Tim, Luo Wenli, Maroni, Bradley J, Matsushita Kunihiro, McCullough, Peter A, Parfrey, Patrick S, Roy-Chaudhury, Prabir, Sarnak, Mark J, Sharma, Amit, Spinowitz Bruce, Tseng, Carol, Tumlin, James, Vargo, Dennis L, Walters, Kimberly A, Winkelmayer, Wolfgang C, Wittes Janet, Eckardt Kai-Uwe
Gepubliceerd in:	Massachusetts Medical Society
Onderwerpen:	Akebia Therapeutics Inc United States > US Hemodialysis Clinical trials Hypoxia-inducible factors Hemoglobin Cerebral infarction Collaboration Kidney diseases Heart failure Hypoxia Myocardial infarction Confidence intervals Erythropoietin Thromboembolism Drug dosages Erythropoiesis Patients Hydroxylase Anemia Heart attacks Prolyl hydroxylase Design Safety Congestive heart failure Dialysis
Online toegang:	Citation/Abstract Full Text Full Text - PDF
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Wees de eerste die reageert!